arecaidine has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calogero, A; Carbone, A; Coccia, A; De Falco, E; Di Bari, M; Pacini, L; Pastore, AL; Petrozza, V; Ponti, D; Siciliano, C; Tata, AM | 1 |
1 other study(ies) available for arecaidine and Bladder Cancer
| Article | Year |
|---|---|
M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.
Topics: Arecoline; Biopsy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Gene Expression; Humans; Muscarinic Antagonists; Neoplasm Grading; Receptor, Muscarinic M2; Urinary Bladder Neoplasms | 2014 |